Skip to content

Acute and chronic effects of walking exercise training with or without blood flow restriction on serum BDNF levels, gait and severity in patients with Parkinson's disease

Acute and chronic effects of walking exercise training with or without blood flow restriction on serum BDNF levels, gait and severity in patients with Parkinson's disease

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20241016001
Enrollment
24
Registered
2024-10-16
Start date
2024-06-24
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with 2-3 stage Parkinson&#039

Interventions

Eight participants in the CON group. No intervention with standard care.,Eight participants in the WALK group practiced walking exercise training for 15 min x 2 sets, (rest for 1 min between a set) at
s Disease Rating Scale (UPDRS): An evaluation of the severity of Parkinson&#039
s disease symptoms. - Parkinson&#039
s Disease Quality of Life Questionnaire-8 (PDQ-8): A quality-of-life assessment for patients with Parkinson&#039
s disease. 2. The collect blood chemical variables to measure as follows: BDNF levels by drawing blood from the inner elbow (antecubital vein). And a fingerstick blood test to measure blood lactate le
Control Group (CON),Walking Group (WALK),Walking with Blood Flow Restriction Group (WBFR)

Sponsors

Faculty of Physical Education
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Male and female with Parkinson's disease at least than 50 years old 2. Hoehn and Yahr staging between 2 and 3 3. Walk at least 10 meters without assistance 4. Risk assessment passed by a Neurologist

Exclusion criteria

Exclusion criteria: 1. Dementia, or previously diagnosed with anxiety or depressive disorders 2. TMSE assessment <23 scores 3. Denied participation in the study

Design outcomes

Primary

MeasureTime frame
Brain-derived neurotrophic factor baseline and after 8 weeks of training Human BDNF ELISA Kit

Secondary

MeasureTime frame
Cognitive function baseline and after 8 weeks of training Thai Mental State Examination (TMSE) scores,Quality of life baseline and after 8 weeks of training Parkinson's Disease Quality of Life (PDQ-8) Questionnaire,Disease Severity baseline and after 8 weeks of training Unified Parkinson's Disease Rating Scale (UPDRS) ,Blood lactate before and after of acute experimental Lactate meter,Blood pressure baseline and after 8 weeks of training Blood pressure monitor,Body Composition (As follows: Body mass index, Body weight, Visceral fat, Body fat percentage, Basal metabolic rate, and Skeletal muscle mass percentage) baseline and after 8 weeks of training Body composition monitor,Calf Circumference baseline and after 8 weeks of training Body tape measure,Thigh Circumference baseline and after 8 weeks of traning Body tape measure,Functional performance (1); strength, movements, balance baseline and after 8 weeks of traning Five times sit-to-stand test ,Functional performance (2); stability, gait, stride length, sway baseline and after 8 weeks of training Time up and go test ,Functional performance (3); gait speed baseline and after 8 weeks of training 10-meter walk test ,Brachial-ankle pulse wave velocity baseline and after 8 weeks of training Pulse wave velocity machine,Flow-mediated dilation baseline and after 8 weeks of training Ultrasound portable machine and Popliteal analyzer for research program,Muscle oxygenation during walking exercise 30 minutes of acute experimental Near-infrared spectroscopy

Countries

Thailand

Contacts

Public ContactKetsirin Kittipongphakorn

Srinakharinwirot University

tle.winner@gmail.com026495000

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026